Combination of ICSs and LABAs should be used in the management of patients with COPD--the pro argument.
Sin
Don D
DD
James Hogg iCapture Centre for Cardiovascular and Pulmonary Research, Department of Medicine, University of British Columbia, Vancouver. dsin@mrl.ubc.ca
D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D058666:Adrenergic beta-2 Receptor Agonists; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005541:Forced Expiratory Volume; D006304:Health Status; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000503:physiopathology; D011788:Quality of Life; D018343:Receptors, Adrenergic, beta-2 / Q000627:therapeutic use*; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D058666:Adrenergic beta-2 Receptor Agonists; D003692:Delayed-Action Preparations; D018343:Receptors, Adrenergic, beta-2